Koningstein M - Search Results

1

Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands.

Koningstein M, van der Bij AK, de Kraker ME, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, Leverstein-van Hall MA; ISIS-AR Study Group. Koningstein M, et al. PLoS One. 2014 Jan 28;9(1):e86634. doi: 10.1371/journal.pone.0086634. eCollection 2014. PLoS One. 2014. PMID: 24489755 Free PMC article.

2

Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027.

van der Kooi TII, Koningstein M, Lindemans A, Notermans DW, Kuijper E, van den Berg R, Boshuizen H, Filius PMG, van den Hof S. van der Kooi TII, et al. Among authors: koningstein m. J Med Microbiol. 2008 Jun;57(Pt 6):709-716. doi: 10.1099/jmm.0.47711-0. J Med Microbiol. 2008. PMID: 18480327

3

The use of typing methods and infection prevention measures to control a bullous impetigo outbreak on a neonatal ward.

Koningstein M, Groen L, Geraats-Peters K, Lutgens S, Rietveld A, Jira P, Kluytmans J, de Greeff SC, Hermans M, Schneeberger PM. Koningstein M, et al. Antimicrob Resist Infect Control. 2012 Nov 20;1(1):37. doi: 10.1186/2047-2994-1-37. Antimicrob Resist Infect Control. 2012. PMID: 23168170 Free PMC article.

4

Prevalence and Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant Escherichia coli in Children Attending Daycare Centers: A Cohort Study in the Netherlands.

Koningstein M, Leenen MA, Mughini-Gras L, Scholts RM, van Huisstede-Vlaanderen KW, Enserink R, Zuidema R, Kooistra-Smid MA, Veldman K, Mevius D, van Pelt W. Koningstein M, et al. J Pediatric Infect Dis Soc. 2015 Dec;4(4):e93-9. doi: 10.1093/jpids/piv042. Epub 2015 Jul 27. J Pediatric Infect Dis Soc. 2015. PMID: 26407274

5

The interaction between prior antimicrobial drug exposure and resistance in human Salmonella infections.

Koningstein M, Simonsen J, Helms M, Mølbak K. Koningstein M, et al. J Antimicrob Chemother. 2010 Aug;65(8):1819-25. doi: 10.1093/jac/dkq176. Epub 2010 May 27. J Antimicrob Chemother. 2010. PMID: 20507862

6

Antimicrobial use: a risk factor or a protective factor for acquiring campylobacteriosis?

Koningstein M, Simonsen J, Helms M, Hald T, Mølbak K. Koningstein M, et al. Clin Infect Dis. 2011 Oct;53(7):644-50. doi: 10.1093/cid/cir504. Clin Infect Dis. 2011. PMID: 21890769

7

Human beings are highly susceptible to low doses of Trichinella spp.

Teunis PF, Koningstein M, Takumi K, van der Giessen JW. Teunis PF, et al. Among authors: koningstein m. Epidemiol Infect. 2012 Feb;140(2):210-8. doi: 10.1017/S0950268811000380. Epub 2011 Apr 14. Epidemiol Infect. 2012. PMID: 21489335

8

Efficient C2 functionalisation of 2H-2-imidazolines.

Bon RS, Sprenkels NE, Koningstein MM, Schmitz RF, de Kanter FJ, Dömling A, Groen MB, Orru RV. Bon RS, et al. Among authors: koningstein mm. Org Biomol Chem. 2008 Jan 7;6(1):130-7. doi: 10.1039/b713065a. Epub 2007 Nov 8. Org Biomol Chem. 2008. PMID: 18075657

9

Multicomponent synthesis of dihydropyrimidines and thiazines.

Vugts DJ, Koningstein MM, Schmitz RF, de Kanter FJ, Groen MB, Orru RV. Vugts DJ, et al. Among authors: koningstein mm. Chemistry. 2006 Sep 18;12(27):7178-89. doi: 10.1002/chem.200600168. Chemistry. 2006. PMID: 16847990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page